期刊
AAPS JOURNAL
卷 9, 期 2, 页码 E171-E180出版社
SPRINGER
DOI: 10.1208/aapsj0902019
关键词
T-cells; noninvasive imaging; drug delivery; nanoparticles
资金
- NIBIB NIH HHS [EB000487] Funding Source: Medline
- NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R56EB000487, R01EB000487] Funding Source: NIH RePORTER
The T-cell response defines the pathogenesis of many common chronic disease states, including diabetes, rheumatoid arthritis, and transplant rejection. Therefore, a diagnostic strategy that visualizes this response can potentially lead to early therapeutic intervention, avoiding catastrophic organ failure or prolonged sickness. In addition, the means to deliver a drug dose to those cells in situ with the same specificity used to image those cells would provide for a powerful therapeutic alternative for many disease states involving T cells. In this report, we review emerging nanosystems that can be used for simultaneous tracking and drug delivery to those cells. Because of their versatility, these systems-which combine specific receptor targeting with an imaging agent and drug delivery-are suited to both basic science and applications, from developing therapeutic strategies for autoimmune and alloimmune diseases, to noninvasive tracking of pathogenic T-cell migration.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据